Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

27 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
[Myelodysplastic syndrome (preleukemia)].
Wickramanayake PD, Pallenschat J, Diehl V. Wickramanayake PD, et al. Med Klin (Munich). 1991 Mar 15;86(3):157-64. Med Klin (Munich). 1991. PMID: 2034179 Review. German. No abstract available.
[Adjuvant systemic therapy of breast carcinoma].
Wickramanayake PD, Katay I, Josting A, Diehl V. Wickramanayake PD, et al. Med Klin (Munich). 1996 Oct 15;91(10):646-53. Med Klin (Munich). 1996. PMID: 9019642 Review. German. No abstract available.
Favorable outcome of patients with relapsed or refractory Hodgkin's disease treated with high-dose chemotherapy and stem cell rescue at the time of maximal response to conventional salvage therapy (Dex-BEAM).
Josting A, Kàtay I, Rueffer U, Winter S, Tesch H, Engert A, Diehl V, Wickramanayake PD. Josting A, et al. Among authors: wickramanayake pd. Ann Oncol. 1998 Mar;9(3):289-95. doi: 10.1023/a:1008283909959. Ann Oncol. 1998. PMID: 9602263 Clinical Trial.
Dexamethasone, carmustine, etoposide, cytarabine, and melphalan (dexa-BEAM) followed by high-dose chemotherapy and stem cell rescue--a highly effective regimen for patients with refractory or relapsed indolent lymphoma.
Josting A, Reiser M, Wickramanayake PD, Rueffer U, Draube A, Söhngen D, Tesch H, Wolf J, Diehl V, Engert A. Josting A, et al. Among authors: wickramanayake pd. Leuk Lymphoma. 2000 Mar;37(1-2):115-23. doi: 10.3109/10428190009057634. Leuk Lymphoma. 2000. PMID: 10721775 Clinical Trial.
Dexa-BEAM: an effective regimen for cytoreduction prior to high-dose chemotherapy with autologous stem cell support for patients with relapsed/refractory mantle-cell lymphoma.
Josting A, Reiser M, Wickramanayake PD, Rueffer U, Draube A, Söhngen D, Tesch H, Wolf J, Diehl V, Engert A. Josting A, et al. Among authors: wickramanayake pd. Leuk Lymphoma. 2000 Mar;37(1-2):185-7. doi: 10.3109/10428190009057644. Leuk Lymphoma. 2000. PMID: 10721785 Clinical Trial.
27 results